Nilsine Partners’s Idexx Laboratories IDXX Stock Holding History

Nilsine Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-408	Closed	-$205K	–	362
2023 Q2	$205K	Sell	408 -27	-6%	-$12.9K	0.03%	337
2023 Q1	$218K	Buy	+435	New	+$208K	0.03%	324

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Nilsine Partners's IDXX Position: Q3 2023 in Review

Nilsine Partners sold out of Idexx Laboratories (IDXX) in Q3 2023, closing a stake of 408 shares — an estimated $205K sold.

Nilsine Partners first reported a position in IDXX in Q1 2023 and held it in 2 quarters. The position peaked at $218K in Q1 2023. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

Nilsine Partners reported no remaining Idexx Laboratories position as of Q3 2023 after selling out during the quarter.
Nilsine Partners sold 408 Idexx Laboratories shares in Q3 2023, an estimated $205K.
Nilsine Partners first reported a position in Idexx Laboratories in Q1 2023 and held it in 2 quarters.
Nilsine Partners's Idexx Laboratories position peaked at $218K in Q1 2023.
1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Nilsine Partners's 13F filing for Q3 2023, filed 1 Nov 2023.